FMP

FMP

Blog
Screener
Extras

TRIL - Trillium Therapeutics Inc.

Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. The company's lead program is TTI-621, a S

photo-url-https://financialmodelingprep.com/image-stock/TRIL.jpg

Trillium Therapeutics Inc.

TRIL

NASDAQ

18.44 USD

0 (0.00%)

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep